Reimbursement in Taiwan
Reimbursement for Medical Devices in Taiwan
Reimbursement for Pharmaceuticals/Drugs in Taiwan
The universal healthcare system of Taiwan, known as the National Healthcare Insurance Program (NHI), has existed since 1995. The NHI regulator, the Bureau of National Health Insurance (BNHI), usually runs deficits, making them especially interested in cost-cutting measures with respect to medical products.
The BNHI usually determines prices for new medical products by comparing them with similar products on the market. If there are no similar products on the Taiwanese market, the BNHI examines existing prices in other countries and usually selects a figure in the low range of those existing prices.
PBM can devise and implement a strategy to get the optimal Taiwanese reimbursement prices for successful sales in Taiwan. PBM can help balance optimal pricing issues with time to market.
For more information on reimbursement in Taiwan, please see the following PBM publications and/or contact us to discuss your specific needs.
- Taiwan Medical Device Regulations (presentation for sale)
- Medical Device Reimbursement in Taiwan
- Drug and Device Markets Throughout the Asian Region (PDF)
- Taiwan: New Pharmaceutical Regulatory Trends
Blog/RSS